The largest database of trusted experimental protocols

B27 complete supplement

Manufactured by Thermo Fisher Scientific
Sourced in United States

B27 complete supplement is a cell culture media additive that provides a defined, serum-free formulation to support the growth and differentiation of neural, stem, and other cell types. The supplement contains a mixture of vitamins, hormones, antioxidants, and other components that support cell survival and proliferation.

Automatically generated - may contain errors

3 protocols using b27 complete supplement

1

Generation of Cardiomyocytes from Human iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Skin fibroblasts were obtained from a healthy volunteer and reprogrammed into pluripotent stem cells by standard methods. HiPSCs from a patient with LQT3 were previously described40 (link). Human iPSCs were maintained in Essential 8 media and passaged every 3–5 days as single cells on Geltrex-coated plastic dishes (Invitrogen). Differentiation was performed as described elsewhere by sequential inhibition of GSK3 and the Wnt signaling pathways49 (link), 50 (link). Spontaneously beating CMs between days 20 and 30 were dissociated with 0.25% Trypsin-EDTA (GIBCO), re-plated on Geltrex-coated 96-well plates and maintained in RPMI 1640 medium with B27 complete supplement (Invitrogen) as described previously50 (link).
+ Open protocol
+ Expand
2

Cardiomyocyte Differentiation from iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
iPSCs were cultured on Matrigel (GFR, BD Biosciences, Franklin Lakes, NJ, USA) coated plates in mTeSR1 medium (StemCell Technologies, Vancouver, Canada) at 37 °C. Cardiomyocyte differentiation was performed by modulating Wnt/β-catenin signaling, applying small molecules as previously described by Lian et al. [47 (link)]. iPSCs were dissociated mechanically or enzymatically with Versene solution (Invitrogen, Life Technologies, Woburn, MA, USA) and were seeded in 6-well or 12-well plates containing mTeSR1 medium supplemented in some cases with 5 μmol/L ROCK inhibitor (Cayman Chemical, Ann Arbor, MI, USA). Cells were maintained for additional 1–4 days (with mTeSR1 medium replaced every 1–3 days) before the beginning the differentiation protocol (day 0). On day 0, medium was changed to RPMI supplemented with B27 minus insulin (In vitrogen, Life Technologies, Woburn, MA, USA) and 8 or 10 μmol/L CHIR99021. On the next day (day 1), the medium was changed to RPMI supplemented with B27 minus insulin. On day 3, the medium was changed to RPMI supplemented with B27 minus insulin and 5 or 10 μmol/L IWP-4. On day 5, the medium was changed to RPMI supplemented with B27 minus insulin. From day 7 onwards, cells were cultured in RPMI supplemented with B27 complete supplement (Invitrogen), and medium was replaced 2–3 times a week.
+ Open protocol
+ Expand
3

Directed Differentiation of iPSCs to Cardiomyocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
iPSC-CMs were generated according to the directed differentiation by modulating Wnt/β-catenin signaling as previously described5 (link). Briefly, iPSCs were cultured on Matrigel (GFR, BD Biosciences, Franklin Lakes, NJ, USA) coated 6-well plates with mTeSR1 medium (Stemcell Technologies, Vancouver, Canada) for 5–6 days. To initiate differentiation, the cells were dissociated using 1 ml/well Versene solution (Invitrogen, Life Technologies, Woburn, MA, USA) at 37°C for 7 minutes and reseeded on Matrigel coated plate at 8.5x106/12 well plate density in mTeSR1 medium supplemented with 5 μmol/l ROCK inhibitor (Cayman Chemical, Ann Arbor, MI, USA). The medium was replaced daily, and after 2 days when the monolayer of cells reached 100% confluence, the medium was changed to RPMI supplemented with B27 minus insulin (Invitrogen, Life Technologies, Woburn, MA, USA) containing 10 μmol/l CHIR99021; this day was labelled as day 1 of differentiation. On the next day, the medium was changed to RPMI supplemented with B27 minus insulin. On day 4, the medium was changed to RPMI supplemented with B27 minus insulin, containing 10 μmol/l of IWP-4 or 2. On day 6, the medium was changed to RPMI supplemented with B27 minus insulin. Finally, from day 8 onwards, the medium was changed to RPMI supplemented with B27 complete supplement (Invitrogen, Life Technologies, Woburn, MA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!